Retinitis pigmentosa: A Case Report with Thr17Arg as a Novel Mutation in RHO Gene.

Document Type : Original Article

Authors

1 Cellular, Molecular, and Genetics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Dept of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.

Abstract

Background and Aim: Retinitis pigmentosa (RP) is the most common type of inherited progressive photoreceptor cells degeneration causing night blindness, progressive reduction of visual field, loss of retinal pigment epithelial function, and ultimately tubular vision and blindness. Retinitis pigmentosa is most commonly inherited in three ways: autosomal dominant, autosomal recessive, or X-linked, although mitochondrial inheritance also occurs. Mutations in the RHO gene are the most widely associated reason with Retinitis pigmentosa (20-30%). This study aims to find Retinitis pigmentosa likely pathogenic mutation in order to Whole Exome sequencing and Sanger confirmation. Methods & Materials: The patient is an 8-year-old child who presented to a physician following reduced vision in low light, decreased night vision, decreased peripheral vision, and blurred vision. Considering the symptoms of Retinitis pigmentosa, which were observed mildly in their paternal grandparents and severely in aunts; the patient's DNA was extracted and used for molecular studying and sequencing. Results: In the present study, we report a novel likely pathogenic mutation c.50C>G/ p.Thr17Arg in one affected child of a consanguineous family, which occurs in the coding region of RHO. The autosomal dominant inheritance pattern was confirmed by Sanger since the father of our proband was heterozygous for the mutation. Conclusion: Since date, c.50C>G/ p.Thr17Arg likely pathogenic variant has not been observed or reported globally. This mutation disrupts the function of the RHO protein and impairs the translocation of this transmembrane protein, causing symptoms of Retinitis pigmentosa. According to family history and molecular studies, the inheritance of the gene in the family is AD, and these findings will be very significant for subsequent pregnancies in this family.

Keywords

Main Subjects

References

Ali, M. U., Rahman, M. S. U., Cao, J., & Yuan, P. X. J. B. (2017). Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario. 7(4), 1-20.
Aref Eshghi, E. J. M. S. J. o. I. A. U.-T. M. B. (2012). Genetic and demographic analysis of retinitis pigmentosa in Iran during 2007-2008. 22(1), 78-84.
Busskamp, V., Picaud, S., Sahel, J.-A., & Roska, B. J. G. t. (2012). Optogenetic therapy for retinitis pigmentosa. 19(2), 169-175.
Ewing, B., & Green, P. J. G. r. (1998). Base-calling of automated sequencer traces using phred. II. Error probabilities. 8(3), 186-194.
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. J. G. r. (1998). Base-calling of automated sequencer traces usingPhred. I. Accuracy assessment. 8(3), 175-185.
Ionita-Laza, I., McCallum, K., Xu, B., & Buxbaum, J. D. J. N. g. (2016). A spectral approach integrating functional genomic annotations for coding and noncoding variants. 48(2), 214-220.
Kabir, F., Ullah, I., Ali, S., Gottsch, A. D., Naeem, M. A., Assir, M. Z., . . . Ayyagari, R. J. M. v. (2016). Loss of function mutations in RP1 are responsible for retinitis pigmentosa in consanguineous familial cases. 22, 610.
Liu, X., Li, C., Mou, C., Dong, Y., & Tu, Y. J. G. m. (2020). dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. 12(1), 1-8.
Miller, N., Lacroix, E.-M., & Backus, J. E. J. B. o. t. M. L. A. (2000). MEDLINEplus: building and maintaining the National Library of Medicine's consumer health Web service. 88(1), 11.
Mitchell, J., Balem, F., Tirupula, K., Man, D., Dhiman, H. K., Yanamala, N., . . . Gerwert, K. J. P. o. (2019). Comparison of the molecular properties of retinitis pigmentosa P23H and N15S amino acid replacements in rhodopsin. 14(5), e0214639.
Parmeggiani, F., Barbaro, V., De Nadai, K., Lavezzo, E., Toppo, S., Chizzolini, M., . . . Di Iorio, E. J. S. r. (2016). Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia. 6(1), 1-8.
Patrizi, C., Llado, M., Benati, D., Iodice, C., Marrocco, E., Guarascio, R., . . . Recchia, A. J. T. A. J. o. H. G. (2021). Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model. 108(2), 295-308.
Quang, D., Chen, Y., & Xie, X. J. B. (2015). DANN: a deep learning approach for annotating the pathogenicity of genetic variants. 31(5), 761-763.
Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. J. N. m. (2014). MutationTaster2: mutation prediction for the deep-sequencing age. 11(4), 361-362.
series, H. Q. O. J. O. h. t. a. (2016). Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment. 16(14), 1.
Shihab, H. A., Rogers, M. F., Gough, J., Mort, M., Cooper, D. N., Day, I. N., . . . Campbell, C. J. B. (2015). An integrative approach to predicting the functional effects of non-coding and coding sequence variation. 31(10), 1536-1543.
Sun, Y., Li, W., Li, J. k., Wang, Z. s., Bai, J. y., Xu, L., . . . medicine, g. (2020). Genetic and clinical findings of panel‐based targeted exome sequencing in a northeast Chinese cohort with retinitis pigmentosa. 8(4), e1184.
Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., . . . Bork, P. J. N. a. r. (2021). The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. 49(D1), D605-D612.
Talib, M., van Cauwenbergh, C., van Schooneveld, M. J., Fiocco, M., Wijnholds, J., Jacoline, B., . . . van Genderen, M. M. J. R. (2021). Clinical characteristics and natural history of rho-associated retinitis pigmentosa: A long-term follow-up study. 41(1), 213-223.
Tezel, T. H., & Ruff, A. J. T. J. o. O. (2021). Retinal cell transplantation in retinitis pigmentosa. 11(4), 336.
Tian, Y., Pesaran, T., Chamberlin, A., Fenwick, R. B., Li, S., Gau, C.-L., . . . Qian, D. J. S. r. (2019). REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification. 9(1), 1-6. 

Files

History

  • Receive Date: 30 January 2022
  • Revise Date: 01 February 2022
  • Accept Date: 19 February 2022

Share

How to cite

Statistics